Inhaled corticosteroids and wheezing post-bronchiolitis;Glucocorticoides inhalados y sibilancias posbronquiolitis

Anales Espanoles de Pediatria

Volumn 52, Issue 4, 2000, Pages 351-355

  Callen Blecua M ^a   Aizpurua Galdeano, P ^a   Ozcoidi Erro, I ^a   Mancisidor Aguinagalde, L ^a   Guedea Adiego, C ^a   Busselo Ortega, E ^a   Ibarrondo Uriarte, I ^a  

^a CAP de Amara Centro   (Spain)

Author keywords

Bronchiolitis; Infants; Inhaled corticosteroids; Wheezing

Indexed keywords

BECLOMETASONE; CORTICOSTEROID;

ARTICLE; BRONCHIOLITIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DISEASE SEVERITY; HUMAN; INCIDENCE; INFANT; INHALER; MAJOR CLINICAL STUDY; MULTICENTER STUDY; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; TREATMENT OUTCOME; WHEEZING;

ADMINISTRATION, INHALATION; BECLOMETHASONE; BRONCHIOLITIS; FEMALE; GLUCOCORTICOIDS; HUMANS; INFANT; MALE; RESPIRATORY SOUNDS; SINGLE-BLIND METHOD;

EID: 0034449757     PISSN: 03024342     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Bronchiolitis as a possible cause of wheezing in childhood: New evidence
2. Continuing respiratory problems three and a half years after acute viral bronchiolitis
3. Respiratory status and allergy after bronchiolitis
4. Long-term prospective study in children after respiratory syncytial virus infection
5. A 2- to 3-year outcome after bronchiolitis
6. Diminished lung function as a predisposing factor for wheezing respiratory illness in infants
7. Airway responsiveness in infants following bronchiolitis
8. The relationship of respiratory infections in early childhood to the occurrence of increased levels of bronchial responsiveness and atopy
9. Respiratory syncytial virus-specific IgE antibody responses at the mucosal surface: Predictive value for recurrent wheezing and suppression by ribavirin therapy
10. The predictive relationship between serum IgE levels ar birth and subsequent incidences of lower respiratory illnesses and eczema in infants
11. Bronchiolitis and asthma: Are they related?
12. Inhaled budesonide for treatment of recurrent wheezing in early childhood
13. The functional response of infants with persistent wheezing to nebulized beclomethasone dipropionate
14. Inhaled budesonide for chronic wheezing under 18 months of age
15. Randomised controlled trial of budesonide for the prevention of post-bronchiolitis wheezing
16. Early nebulized budesonide in the treatment of bronchiolitis and the prevention of postbronchiolitic wheezing
17. One-year follow-up of young children hospitalized for wheezing: The influence of early anti-inflammatory therapy and risk factors for subsequent wheezing and asthma
18. Anti-inflammatory therapy reduces wheezing after bronchiolitis
19. Comparison of two nebulized treatments in wheezing infants
20. Serum immunoglobulin E in atopic and non-atopic children aged 6 months to 5 years. A follow-up study
21. Prevalencia y factores de riesgo de asma en Guipuzcoa. Estudio multicéntrico caso-control
22. Nebulised beclomethasone dipropionate in recurrent obstructive episodes after acute bronchiolitis
23. Risks of developing asthma
24. Bronchiolitis and asthma in infancy and early childhood
25. Respiratory syncytial virus in early life and risk of wheeze and allergy by age 13 years